Transit Passes for People with HIV

Overseen By Jay Orne, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: The Aliveness Project

Disqualifiers: Informed consent, English, Aliveness member

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

146 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this trial is to learn if providing an unlimited transit pass will improve the health of people living with HIV that are experiencing unstable housing. The main questions it aims to answer are: 1. Do participants who are provided the transit pass manage their HIV better? 2. Do participants who are provided the transit pass use other social services more that could improve their health and quality of life? Researchers will compare the group that is provided with the transit pass to a control group that is not provided with the pass. Participants will fill out a baseline survey and a follow-up survey after 6 months. Researchers will also look at participant's HIV lab tests to see how well their HIV is being managed.

Research Team

Jay Orne, PhD

Principal Investigator

The Aliveness Project

Eligibility Criteria

This trial is for people living with HIV who don't have stable housing. Participants should be willing to complete surveys and allow access to their HIV lab tests. There are no specific exclusion criteria provided, but typically participants would need to meet certain health standards.

Inclusion Criteria

Be a person experiencing unstable housing or homelessness

Currently lives in a temporary group home or substance abuse treatment program, but lived in one of the above housing conditions prior to entry within the last three months

Is listed in the CAREWare database system as being homeless or having temporary or unstable housing

Exclusion Criteria

Not an Aliveness member in good standing

I cannot communicate in English.

Inability to provide informed consent

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants fill out a baseline survey and undergo initial assessments

1 week

1 visit (in-person)

Intervention

Participants in the intervention group receive unlimited transit passes for 6 months

6 months

Follow-up

Participants complete a follow-up survey and researchers assess HIV management outcomes

6 months

1 visit (in-person)

Treatment Details

Interventions

• Metro Transit Pass

Trial Overview The study is testing whether giving out unlimited transit passes can help improve the management of HIV and increase the use of social services among unstably housed individuals. It compares a group with these passes against one without, over six months.

Participant Groups

Group I: Intervention Group Experimental Treatment 1 Intervention

The intervention group will be provided a transit pass for the Minneapolis Metro transit system that will be paid for by the study for 6 months.

Group II: Control Active Control 1 Intervention

The control group will receive the current standard of care, in which people are eligible to receive up to two $10 bus cards from their case manager per month.

Who Is Running the Clinical Trial?

The Aliveness Project

Lead Sponsor

Trials

1

Recruited

150+